Vaccine maker Emergent s CEO sold $10 million in stock before company ruined Johnson & Johnson doses washingtonpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from washingtonpost.com Daily Mail and Mail on Sunday newspapers.
CEO of vaccine maker sold $10 million in stock before company ruined Johnson & Johnson doses
By Jon Swaine The Washington Post,Updated April 26, 2021, 2 hours ago
Email to a Friend
The Emergent BioSolutions plant in Baltimore, Maryland.Tasos Katopodis/Getty Images via Bloomberg
The stock price of government contractor Emergent BioSolutions has fallen sharply since the disclosure at the end of March that production problems at the firmâs plant in Baltimore had ruined 15 million doses of Johnson & Johnsonâs coronavirus vaccine. Since then, AstraZeneca moved production of its own vaccine out of the facility, and Emergent temporarily halted work there altogether.
CEO of vaccine maker sold $10 million in stock before company ruined Johnson & Johnson dose pressherald.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pressherald.com Daily Mail and Mail on Sunday newspapers.